Pet M&A slows, but firmer valuations may support a rebound
Bottom line
Pet industry dealmaking slowed in early 2026, even as valuations improved, a combination that could set up a more active second half if buyers and sellers align on price. GlobalPETS reported that deal count fell 19.2% year over year across veterinary, animal health, pet services, and consumables, while average valuation multiples rose, reflecting a market that’s still cautious, but more willing to pay for high-quality assets. That fits with broader 2026 market signals: Lincoln International said in March it was seeing strong interest from strategic and financial buyers and expected an M&A uptick, while other sector coverage has described buyers as increasingly selective and focused on durable, differentiated businesses. (globalpetindustry.com)
Why it matters: For veterinary professionals, a slower deal market doesn’t mean consolidation pressure has disappeared. It likely means buyers are being more disciplined, favoring practices, service platforms, and animal health businesses with stronger margins, clearer differentiation, and steadier demand. That matters in a market where consolidation and corporatization remain a top concern: Brakke Consulting’s 2026 sentiment index found corporatization of veterinary clinics was the single most-cited factor dampening optimism, alongside rising product and service costs. If valuations stay firm, well-positioned veterinary assets could still attract interest, even if overall deal volume remains uneven. (brakkeconsulting.com)
What to watch: Watch whether improving valuation confidence translates into more announced veterinary and pet health transactions in late 2026, especially for premium, recurring-revenue, and operationally resilient businesses. (lincolninternational.com)
Pet industry M&A lost momentum in early 2026, but the pricing backdrop appears to be improving. According to GlobalPETS, deal count fell 19.2% year over year across veterinary, animal health, pet services, and consumables, even as average valuation multiples increased significantly. The picture is of a market that hasn’t fully reopened, but is showing signs that stronger assets can still command better prices. (globalpetindustry.com)
That tension follows several years of uneven dealmaking. Petfood Industry reported that announced pet-sector M&A fell to 23 deals in 2025, down from 26 in 2024 and well below the 48 to 58 annual deals recorded during the 2020 to 2022 peak. Analysts tied that slowdown to higher interest rates, valuation gaps, and broader uncertainty, with buyers shifting away from growth-at-any-price and toward profitability, resilience, and differentiated positioning. (petfoodindustry.com)
There are now clearer signs that sentiment is improving, even if volume hasn’t fully followed. Lincoln International said after Global Pet Expo 2026 that it continues to see strong interest from both strategic and financial buyers, with near-term sale processes across brands, private label, and contract manufacturing, and said it is “on the precipice” of an M&A uptick in 2026. In a separate August update on the broader private market, Lincoln said U.S. private-company values rebounded in Q2 2026 and that average buyout multiples in the first half of 2026 remained above the long-term average, even if below 2025 levels. That suggests capital is available, but increasingly selective. (lincolninternational.com)
Within pet, that selectivity appears to be shaping where deals happen first. Petfood Industry, citing Cascadia Capital, said consumables such as food, treats, and supplements remain especially attractive because they offer recurring purchases, customer loyalty, and pricing power. GlobalPETS’ framing, which spans veterinary, animal health, pet services, and consumables, suggests the same dynamic may be carrying over into adjacent categories: investors are still interested, but they’re concentrating on businesses with dependable demand, cleaner operating stories, and clearer paths to growth. That’s an inference, but it’s consistent with how multiple sector observers are describing the 2026 market. (globalpetindustry.com)
Industry commentary also points to a more practical reason for a pickup in activity: time. Petfood Industry reported that many companies acquired during the early-2020s investment surge are now nearing the end of typical private equity hold periods, creating pressure for exits, recapitalizations, or alternative liquidity events. Lincoln similarly said that companies have gained more visibility after navigating difficult market conditions, which could help close the expectation gap that stalled deals earlier. (petfoodindustry.com)
Why it matters: For veterinary professionals, this is less about headline deal count and more about what kinds of businesses investors want now. Brakke Consulting’s 2026 animal health sentiment report found that corporatization of veterinary clinics was the top factor dampening optimism, cited by 26% of respondents, with rising veterinary product and service costs also ranking high. Brakke also noted that revenue per visit has increased while visit frequency has declined, a pattern that may reflect growing price sensitivity among pet parents. In that environment, stronger valuations could encourage more acquisitions of veterinary and animal health assets, but buyers are likely to reward operational efficiency, client retention, service mix, and affordability discipline, not just scale. (brakkeconsulting.com)
That could create a split market for practices and service businesses. Well-run groups with stable teams, healthy margins, and a clear local value proposition may continue to draw interest, while businesses facing staffing strain, softer visit demand, or pricing pressure may find buyers more cautious. For independent veterinary leaders, the takeaway is that consolidation may proceed more slowly than in the peak years, but it may also become more discriminating, with deal terms shaped as much by operating quality as by sector enthusiasm. (brakkeconsulting.com)
What to watch: The next signal will be whether stronger multiples turn into a steadier cadence of announced deals in the second half of 2026, particularly in veterinary services, animal health distribution, diagnostics, pharmacy, and other recurring-revenue segments where buyers can still make the economics work. (globalpetindustry.com)